Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
Global HGH Biosimilars Market Growth 2023-2029
... affect fat and mineral metabolism, and play a key role in human growth and development. Subcutaneous injection of about 80% was absorbed, 5 hours to reach the peak of blood drug concentration, the half-life of ... Read More
-
Generic Pharmaceuticals Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics, Biosimilars), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region And Segment Forecasts, 2023 - 2030
... Generic Pharmaceuticals Market Growth & Trends The global generic pharmaceuticals market is expected to reach over USD 682.9 billion expanding at a CAGR of 8.3% from 2023 to 2030, according to a new study by ... Read More
-
Biosimilars Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... in the sector in 2023 and beyond. The Biosimilars market report analyzes the Biosimilars market growth opportunities, trends, insights, and market size outlook across types, applications, and countries. Biosimilars market dynamics including trends, drivers, growth ... Read More
-
Biosimilar Lymphocyte Modulator Market Size Outlook in 2023 and Beyond: Market Trends, Insights, Growth Opportunities, Market Share and Forecasts by Types, Applications, Countries and Companies to 2030
... to register solid growth in the sector in 2023 and beyond. The Biosimilar Lymphocyte Modulator market report analyzes the Biosimilar Lymphocyte Modulator market growth opportunities, trends, insights, and market size outlook across types, applications, and ... Read More
-
UAE Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027
... Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027 UAE human insulin market is anticipated to register growth with ... Read More
-
2023 Global Biosimilars Market Industry (2029 Outlook)
... three-year historical trend (2017-2020), a three-year forecast estimate trends (2021-2023), and a five-year outlook projection (2024-2029) for 46 countries. Market and product shipments include the total value of all products produced and shipped by all ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Global Bioprocess Analyzers Market Size study & Forecast, by Product (Instrument and Consumables), Application (Antibiotics, Recombinant Proteins, Biosimilars, Other Applications), Type (Substrate Analysis, Metabolite Analysis, and Concentration Detection), and Regional Analysis, 2022-2029
... Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.1% over the forecast period 2022-2029. Bioprocess Analyzers help in the quick ... Read More
-
Biosimilars: US Payer Insights
... US biosimilar sector development. But is that about to change? Will the launch of biosimilar adalimumab re-invigorate the sector? How is the Inflation Reduction Act impacting biosimilars? Why is it critical for developers to educate ... Read More
-
Biosimilars Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current ... Read More
-
Biosimilar Contract Manufacturing Market – Global Outlook & Forecast 2022-2027
... cannot afford life-saving medicines, putting their lives at risk. Producing potentially life-saving drugs that are more accessible and affordable can help today's patients live better lives for a prolonged period and minimize health inequality. Biologic ... Read More
-
Global Biosimilar Insulin Market Growth 2023-2029
... designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's ... Read More
-
Global Biosimilar Market Growth (Status and Outlook) 2023-2029
... manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval. ... Read More
-
Global Interferon Alpha-2a Biosimilar Market Growth 2023-2029
... DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences. LPI (LP Information)' newest research report, the “Interferon ... Read More
-
Global Biosimilar Drug Market Growth 2023-2029
... from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is a ... Read More
-
Global Biologics and Biosimilars Market Growth 2023-2029
... derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in this report is ... Read More
-
2023 Global Forecast for Cardiac Safety Services Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales ... Read More
-
Global Biologics CDMO Market 2022-2028
... edition of the Global Biologics CDMO Market Report. The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global biologics CDMO market. It traces the market’s historic and forecast ... Read More
-
Access Control as a Service Market (ACaaS) by Access Control Models(RBAC, DAC), Service Type (Hosted, Managed, Hybrid), Cloud Deployment (Public Cloud, Private Cloud), Vertical (Commercial, Residential, Government, Retail) Region - Global Forecast to 2027
... global access control as a service market was valued at USD 0.9 billion in 2021 and is projected to reach USD 2.2 billion by 2027, registering a CAGR of 16.4% during the forecast period. The ... Read More
-
Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022
... they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. ... Read More
-
Adalimumab, Infliximab And Etanercept Biosimilars Global Market Opportunities And Strategies To 2031
... management with the critical information they need to assess the global adalimumab, infliximab and etanercept biosimilars market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Biosimilars Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... the biosimilars market may be significant, and it has imposed a great challenge on the pharmaceutical companies focused on biosimilar development. The reduction in the approval by regulatory bodies of non-COVID therapeutics during the current ... Read More
-
SOUTH KOREA DIABETES DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... 2022-2027. The market is estimated to reach a value of more than USD 1 billion by 2027. The COVID-19 pandemic positively impacted the Diabetes Drugs market growth in South Korea. Patients with diabetes, infected with ... Read More
-
CHINA DIABETES CARE DRUGS MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)
... WHO, 20% of persons with diabetes and diabetes-related disorders died in China in January 2020 COVID-19 fatalities. Diabetes affects about one out of every ten COVID-19 patients in China. Diabetes is linked to an increased ... Read More
-
Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic Research Institutes), and Region - Global Forecast to 2027
... 2027 The global biological safety cabinet market is projected to reach USD0.4billion by 2027 from USD0.2billion in 2022, at a CAGR of 8.2% during the forecast period. Market growth is driven by factors such as ... Read More
Research Assistance
